E‐health in self‐care of heart failure patients: promises become reality

Piepoli, Massimo F

doi:10.1002/ejhf.1386

Cited by 3 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Information should be individually tailored and take into account relevant comorbidities that may influence retention of information (such as cognitive impairment and depression), travel to the point of care (physical disability, living alone) or the need for psychosocial support for patients and their family/carers. 68 Home telemonitoring can be useful in the postdischarge period, allowing easier communication, via phone or interactive internet-based interaction, between the patient and the healthcare providers to monitor healthy individuals or chronically ill patients remotely [69][70][71] (Table 1).…”

Section: Transitional Of Care Interventionsmentioning

confidence: 99%

“…Postdischarge strategies include general practitioner and specialist follow-up visits, telephone calls or home visits after discharge, facilitated access to care during periods of decompensation, and coordination of the tertiary healthcare structure wherever needed. Information should be individually tailored and take into account relevant comorbidities that may influence retention of information (such as cognitive impairment and depression), travel to the point of care (physical disability, living alone) or the need for psychosocial support for patients and their family/carers 68 …”

Section: Transitional Of Care Interventionsmentioning

confidence: 99%

Section: Transitional Of Care Interventionsmentioning

confidence: 99%

See 2 more Smart Citations

Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice

Rosano

Vitale

Adamo

et al. 2021

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

Patients discharged after an episode of acute heart failure have an increased risk of hospitalizations and deaths within the subsequent 3 months. This phase is commonly called the 'vulnerable period' and it represents a window of opportunity of intervention in order to improve longer term outcomes. Prompt identification of signs of residual haemodynamic congestion is a priority in planning for the out-of-hospital management strategies. Patients will also need to be screened for frailty and have a prioritization of the management of their comorbidities. Life-saving medications should be started together or in a short time and up-titrated (when needed) according to blood pressure, heart rate and concomitant comorbidities. Ideally, patients should be assessed by their general practitioner within 1 week of discharge and have a hospital/clinic follow-up within 4 weeks of discharge. Patients should progressively resume physical activities and adhere to an educational programme with appropriate lifestyle adjustments best implemented during a cardiac rehabilitation programme.

show abstract

Section: Transitional Of Care Interventionsmentioning

confidence: 99%

Section: Transitional Of Care Interventionsmentioning

confidence: 99%

Section: Transitional Of Care Interventionsmentioning

confidence: 99%

See 1 more Smart Citation

Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice

Rosano

Vitale

Adamo

et al. 2021

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

show abstract

“…It was early interrupted because of slow enrolment, low event rate, and the need of standardize BNP spontaneous fluctuation. 237 The HFA has developed a well-visited tool to assist in patient communication and education, a crucial part of ongoing disease management, 238 which the development of e-health strategies will likely accelerate, 239 as will better mechanisms to enhance dosing choices in guideline-directed HF medication. 240,241 Novel perspectives New therapeutic strategies are emerging for patients with HF of ischaemic aetiology.…”

Section: Telemedicine and Disease Managementmentioning

confidence: 99%

Heart failure in the last year: progress and perspective

et al. 2020

View full text Add to dashboard Cite

Research about heart failure (HF) has made major progress in the last years. We give here an update on the most recent findings. Landmark trials have established new treatments for HF with reduced ejection fraction. Sacubitril/valsartan was superior to enalapril in PARADIGM‐HF trial, and its initiation during hospitalization for acute HF or early after discharge can now be considered. More recently, new therapeutic pathways have been developed. In the DAPA‐HF and EMPEROR‐Reduced trials, dapagliflozin and empagliflozin reduced the risk of the primary composite endpoint, compared with placebo [hazard ratio (HR) 0.74; 95% confidence interval (CI) 0.65–0.85; P < 0.001 and HR 0.75; 95% CI 0.65–0.86; P < 0.001, respectively]. Second, vericiguat, an oral soluble guanylate cyclase stimulator, reduced the composite endpoint of cardiovascular death or HF hospitalization vs. placebo (HR 0.90; 95% CI 0.82–0.98; P = 0.02). On the other hand, both the diagnosis and treatment of HF with preserved ejection fraction, as well as management of advanced HF and acute HF, remain challenging. A better phenotyping of patients with HF would be helpful for prognostic stratification and treatment selection. Further aspects, such as the use of devices, treatment of arrhythmias, and percutaneous treatment of valvular heart disease in patients with HF, are also discussed and reviewed in this article.

show abstract

Care plans for the older heart failure patient

Hill

Carson

Vitale

2019

European Heart Journal Supplements

View full text Add to dashboard Cite

Heart failure (HF) professionals are managing an older population with multiple, often interconnected comorbidities. The average age of the HF patient has increased substantially and many have a number of comorbidities. For the older HF patient, diligent planning of care has the potential to reduce hospitalization, improve quality of life and mortality; nevertheless, this vital component is often overlooked. Frailty, cachexia, sarcopenia, and cognitive impairment are all common in the older HF patient and require special care considerations. Many older HF patients live for many years with troublesome symptoms that could be better addressed through the incorporation of a palliative approach to care. Effective care plans can help patients maximize their health potential through both lifestyle and pharmacological interventions. However, current evidence remains scarce on what constitutes an optimal plan, therefore further studies are urgently needed. We review the care that could be implemented for the complex older HF patient with comorbidities.

show abstract

E‐health in self‐care of heart failure patients: promises become reality

Cited by 3 publications

References 9 publications

Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice

Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice

Heart failure in the last year: progress and perspective

Care plans for the older heart failure patient

Contact Info

Product

Resources

About